Nucala Granted Priority Review For Treatment of Hypereosinophilic Syndrome
PhotoLizM / Pixabay

Nucala Granted Priority Review For Treatment of Hypereosinophilic Syndrome

  According to a drug filing and press release from Pharmaceutical Business Review, the FDA granted a priority review to GlaxoSmithKline for their humanized monoclonal antibody therapy, Nucala (mepolizumab). Currently,…

Continue Reading Nucala Granted Priority Review For Treatment of Hypereosinophilic Syndrome
The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis
Elizabeth M. Dugan, Adam M. Huber, Frederick W. Miller, Lisa G. Rider / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis

  This year, because of COVID-19, many healthcare-related events and symposiums have been moved online. However, that doesn't mean that the insights are any less helpful! In the virtual ACR…

Continue Reading The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis
Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year
source: pixabay.com

Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year

According to a story from Parkinson's News Today, the Vercise system, developed by Boston Scientific as a method of deep brain stimulation, was able to provide benefit to Parkinson's disease…

Continue Reading Parkinson’s Disease: Vercise Deep Brain Stimulation Demonstrates Efficacy for Over a Year

Sixty Year Old Multiple Myeloma Patient in Wuhan, China Treated Successfully with Tocilizumab for COVID-19

  Dr. Changcheng Zheng of the University of Science, China, recently spoke to Cancer Network about a case study indicating that tocilizumab (Actemra) could effectively treat people with multiple myeloma…

Continue Reading Sixty Year Old Multiple Myeloma Patient in Wuhan, China Treated Successfully with Tocilizumab for COVID-19